Open Access

Antibacterial activity of nineteen selected natural products against multi-drug resistant Gram-negative phenotypes

  • Armelle T. Mbaveng1Email author,
  • Louis P. Sandjo2,
  • Simplice B. Tankeo1,
  • Ache R. Ndifor3,
  • Ambassa Pantaleon3,
  • Bonaventure T. Nagdjui3 and
  • Victor Kuete1, 4Email author
SpringerPlus20154:823

https://doi.org/10.1186/s40064-015-1645-8

Received: 26 August 2015

Accepted: 20 December 2015

Published: 30 December 2015

Abstract

The present study was designed to assess the antimicrobial activity of 19 natural products belonging to terpenoids, alkaloids, thiophenes and phenolics against a panel of 14 Gram-negative multidrug-resistant (MDR) bacteria. The results demonstrated that amongst the studied compounds, alkaloids and terpenoids were less active contrary to flavonoids: neocyclomorusin (3) and candidone (6) and isoflavonoids: neobavaisoflavone (8) and daidzein (12). Thiophene, 2-(penta-1,3-diynyl)-5-(3,4-dihydroxybut-1-ynyl)thiophene (17) showed moderate and selective activities. Compounds 3, 6, 8 and 12 displayed minimal inhibitory concentration (MIC) ranged from 4 to 256 μg/mL on all the 14 tested bacteria. MIC values below 10 μg/mL were obtained with 8, 3, 6 and 12 against 50, 42.9, 35.7 and 21.4 % of the tested bacteria. The lowest MIC value of 4 μg/mL was obtained with compound 3 against Klebsiella pneumoniae ATCC11296, Enterobacter cloacae BM47, compound 6 against Escherichia coli ATCC8739, K. pneumoniae ATCC11296, E. cloacae BM47 and compound 8 against K. pneumoniae ATCC11296 and E. cloacae BM47. The activity of flavonoid 3 was better or equal to that of chloramphenicol in all tested K. pneumoniae, Providencia stuartii, E. aerogenes, E. cloacae and Pseudomonas aeruginosa strains. Within isoflavonoids, neobavaisoflavone scaffold was detected as a pharmacophoric moiety. This study indicates that natural products such as 3, 6 and 8 could be explored more to develop antimicrobial drugs to fight MDR bacterial infections.

Keywords

AntibacterialFlavonoidsIsoflavonoidsNatural productsMultidrug resistance

Background

Infectious diseases including bacterial infections continue to be a serious health problem worldwide. Multidrug-resistant (MDR) pathogens considerably increase the mortality and morbidity. In effect, clinically, the continuous emergence of Gram-negative MDR bacteria drastically reduced the efficacy of antibiotic arsenal leading globally to an increase of the frequency of therapeutic failure (Rice 2006). Consequently, new antibacterials are needed to fight these bacterial pathogens, but progress in developing them have been slow (Fischbach and Walsh 2009). Plant kingdom represents an enormous source of new chemotherapeutic agents to tackle microbial infections. Several natural compounds belonging to the usual pharmaceutical library have been tested for their ability to combat resistant bacteria (Fischbach and Walsh 2009; Saleem et al. 2010). More than 450 natural metabolites with antimicrobial activity have been reported in the period 2000–2010 (Saleem et al. 2010). Some of the best plant metabolites from African medicinal plants with antibacterial activity against MDR Gram-negative phenotypes include laurentixanthone B (xanthone), diospyrone and plumbagin (naphthoquinone), isobavachalcone and 4-hydroxylonchocarpin (flavonoids) and MAB3 (coumarin) (Kuete et al. 2010, 2011a). The rationale of this work comes to the fact that secondary metabolites belonging to terpenoids, phenolics and alkaloids previously displayed prominent antibacterial activity against MDR Gram-negative bacteria expressing active efflux pumps (Kuete et al. 2010, 2011a). Therefore, the present study was designed to determine the antibacterial activity of several molecules, including terpenoids, alkaloids, thiophenes and phenolics, against different bacterial strains expressing MDR phenotypes. Furthermore, we highlighted the possible pharmacophoric cores amongst the active compounds.

Results

Studied compounds

Compounds tested in the present study (Fig. 1) were previously or newly isolated from several Cameroonian plants. They include atalantoflavone (1; yellow solid; m.p. 286.2–287.7 °C) (Ouete et al. 2013); 2′-hydroxyatalantoflavone (2; reddish gum) (Ouete et al. 2013); neocyclomorusin (3; yellow solid, m.p. 263.2–266.7 °C) (Ouete et al. 2013; Cho et al. 2011); 2-(3,5-dihydroxyphenyl)benzofuran-5,6-diol (4; yellow oil) (Ouete et al. 2014; Noguchi et al. 1994); 4-hydroxy-2,6-di-(3′,4′-dimethoxyphenyl)-3,7-dioxabicyclo-(3.3.0)octane (5; yellow solid; m.p. 168.5–169.9 °C) (Kuete et al. 2013); candidone (6; yellowish powder; m.p. 95.1–96.2 °C) (Ouete et al. 2013; Kuete et al. 2013); isoneorautenol (7; yellowish solid; m.p. 156.2–157.8 °C) (Nkengfack et al. 1995; Kuete et al. 2014); neobavaisoflavone (8; yellowish oil) (Nkengfack et al. 1994; Kuete et al. 2014); tecleaverdoornine (9; amorphous solid) (Ayafor and Okogun 1982; Sandjo et al. 2014); maculine (10; amorphous solid) (Nunes et al. 2005; Kuete et al. 2008b; Sandjo et al. 2014); deacetylnomilin (11; colorless oil) (Bennett and Hasegawa 1981); daidzein (12; yellowish gum) (Basha et al. 2013); isowighteone (13; yellowish gum) (Wang et al. 2001); dorstenin (14; white solid; m.p. 136–139 °C) (Kuster et al. 1994; Abegaz et al. 2004); herranone (15; colorless solid; m.p. 285–287 °C) (Wiedemann et al. 1999); isogarcinol (16; brown oil) (Marti et al. 2010); 2-(penta-1,3-diynyl)-5-(3,4-dihydroxybut-1-ynyl)thiophene (17; brownish oil) (Shi et al. 2010); ulmoside A (18; brown oil) (Rawat et al. 2009) and 3,4,3′-tri-O-methylellagic acid (19; brown solid; m.p. 282–284 °C) (Gao et al. 2014). These compounds belong to flavonoids (1-3, 6, 18), isoflavonoids (7, 8, 12, 13), benzophenone (16), benzofuran (4), ellagic acid derivative (19), lignan (5), alkaloids (9, 10), terpenoids (11, 15) and thiophene (19). They were tested for their antimicrobial activity on a panel of 14 bacterial strains and the results are summarized in Table 1.
Fig. 1

Chemical structures of tested compounds. Atalantoflavone (1); 2′-hydroxyatalantoflavone (2); neocyclomorusin (3); 2-(3,5-dihydroxyphenyl)benzofuran-5,6-diol (4); 4-hydroxy-2,6-di-(3′,4′-dimethoxyphenyl)-3,7-dioxabicyclo-(3.3.0)octane (5); Candidone (6); isoneorautenol (7); neobavaisoflavone (8); tecleaverdoornine (9); maculine (10); deacetylnomilin (11); daidzein (12); isowighteone (13); dorstenin (14); herranone (15); 2-(penta-1,3-diynyl)-5-(3,4-dihydroxybut-1-ynyl)thiophene (17); isogarcinol (16); ulmoside A (18) and 3,4,3′-tri-O-methylellagic acid (19)

Table 1

MICs and MBCs (µg/mL) of the nineteen tested compounds and ciprofloxacin on the panel of tested bacteria

Samples

Bacterial strains, MIC and MBC (µg/mL)

Escherichia coli

Enterobacter aerogenes

Klebsiella pneumoniae

Providencia stuartii

Enterobacter cloacae

Pseudomonas aeruginosa

ATCC 8739

AG102

AG100 Atet

ATCC 13048

CM64

EA27

ATCC 11296

KP55

ATCC29916

PS299645

BM47

BM67

PA01

PA124

1

256 (–)

256 (–)

128 (–)

2

256 (–)

256 (–)

256 (–)

3

8 (16)

32 (128)

32 (128)

8 (16)

32 (128)

16 (64)

4 (8)

8 (16)

8 (32)

32 (64)

4 (8)

16 (128)

32 (128)

64 (256)

4

256 (–)

256 (–)

256 (–)

256 (–)

256 (–)

256 (–)

256 (–)

256 (–)

5

256 (–)

6

4 (32)

8 (16)

256 (–)

256 (–)

256 (–)

16 (32)

4 (8)

8 (16)

16 (128)

64 (256)

4(8)

256 (–)

64 (256)

256 (–)

7

256 (–)

256 (–)

256 (–)

8

8 (32)

16 (64)

256 (–)

128 (–)

256 (–)

32 (128)

8 (16)

8 (32)

4 (16)

8 (32)

4 (16)

256 (–)

8 (32)

64 (256)

9

256 (–)

10

256 (–)

256 (–)

11

256 (–)

256 (–)

12

64 (128)

128 (–)

128 (–)

256 (–)

256 (–)

128 (–)

128 (256)

128 (–)

64 (256)

128 (–)

64 (128)

256 (–)

128 (256)

256 (–)

13

128 (–)

128 (–)

256 (–)

256 (–)

14

256 (–)

256 (–)

256 (–)

256 (–)

256 (–)

15

128 (–)

256 (–)

128 (–)

256 (–)

256 (–)

16

17

64 (128)

128 (–)

256 (–)

64 (256)

256 (–)

64 (256)

64 (256)

128 (–)

64 (256)

256 (–)

256 (–)

256 (–)

18

256 (–)

256 (–)

19

64 (256)

256 (–)

256 (–)

128 (–)

256 (–)

256 (–)

64 (256)

256 (–)

16 (64)

32 (256)

256 (–)

256 (–)

CHL

4 (64)

8 (–)

8 (–)

16 (128)

128 (–)

16 (128)

128 (–)

8 (128)

32 (–)

256 (–)

16 (256)

64 (256)

CHL chloramphenicol, (–) MIC > 256 µg/mL, in bold significant antibacterial activity (Kuete 2010; Kuete and Efferth 2010)

Atalantoflavone (1); 2′-hydroxyatalantoflavone (2); neocyclomorusin (3); 2-(3,5-dihydroxyphenyl)benzofuran-5,6-diol (4); 4-hydroxy-2,6-di-(3′,4′-dimethoxyphenyl)-3,7-dioxabicyclo-(3.3.0)octane (5); Candidone (6); isoneorautenol (7); neobavaisoflavone (8); tecleaverdoornine (9); maculine (10); deacetylnomilin (11); daidzein (12); isowighteone (13); dorstenin (14); herranone (15); 2-(penta-1,3-diynyl)-5-(3,4-dihydroxybut-1-ynyl)thiophene (17); isogarcinol (16); ulmoside A (18) and 3,4,3′-tri-O-methylellagic acid (19). Compound classes [flavonoids (1-3, 6, 18), isoflavonoids (7, 8, 12, 13), benzophenone (16), benzofuran (4), ellagic acid derrivative (19), lignan (5), alkaloids (9, 10), terpenoids (11, 15) and thiphene (19)]

Bold values indicate Significant activity

Activity of terpenoids

Both diterpenoid (11) and triterpenoid (15) exhibited very weak activities. Deacetylnomilin (11) and herranone (15) had detectable MIC values against 2/14 (14.3 %) and 5/14 (35.7 %) bacterial strains respectively (Table 1). However, no minimal bactericidal concentration (MBC) value was obtained with the two terpenoids.

Activity of alkaloids

Furoquinoline alkaloids tecleaverdoornine (9) and maculine (10) displayed low activity against the tested bacteria. Their inhibitory effects were observed on 1/14 (7.1 %) and 2/14 (14.3 %) microbial strains, respectively, for 9 and 10 (Table 1).

Activity of thiophene

The compound 2-(penta-1,3-diynyl)-5-(3,4-dihydroxybut-1-ynyl)thiophene (17) showed MIC values below 100 µg/mL against Escherichia coli ATCC 8739, Enterobacter aerogenes ATCC 13048 and EA27, Klebsiella pneumoniae ATCC11296 and Providencia stuartii ATCC29916 (Table 1).

Activity of phenolics (flavonoids, isoflavonoids, benzophenone, benzofuran, coumarins, ellagic acid derrivative and lignan)

The best activities were obtained with phenolic compounds; amongst them, flavonoids neocyclomorusin (3) and candidone (6) as well as isoflavonoids neobavaisoflavone (8) and daidzein (12) had MIC values ranged from 4 to 256 µg/mL on all the 14 tested bacteria. Moreover, MIC values below 10 µg/mL were obtained with 8, 3, 6 and 12 against 7/14 (50 %), 6/14 (42.9 %), 5/14 (35.7 %) and 3/14 (21.4 %) tested bacteria respectively. MIC values below 100 µg/mL were obtained with compound 3 on all tested bacteria. MBC values below 10 µg/mL were also obtained with compound 3 against K. pneumoniae ATCC11296 and Enterobacter cloacae BM47 whilst values ranged from 8 to 256 µg/mL were noted on all tested pathogens. The lowest MIC value of 4 µg/mL was obtained with compound 3 against K. pneumoniae ATCC11296, E. cloacae BM47, compound 6 against E. coli ATCC8739, K. pneumoniae ATCC11296, E. cloacae BM47 and compound 8 against K. pneumoniae ATCC11296 and E. cloacae BM47.

Structure–activity relationship study

When analyzing the structure–activity relationship, it can be observed that terpenoids (both diterpenoids and triterpenoids) as well as the tested furoquinoline alkaloids were poor antimicrobial compounds. A keen look of the activities of phenolics shows that benzophenone (16) were not active meanwhile coumarin (14), lignan (5) and benzofuran (4) were also found to be poor antibacterial agents. The best activities were obtained with flavonoids and isoflavonoids. Within flavonoids, it appeared that hydroxylation of compound 1 to yield 2 did not significantly changed the antibacterial activity (Table 1). The presence of a cyclic prenyl moiety in the heterocyclic portion of flavone 3 improves significantly the activity and provides a large antimicrobial selectivity. Regardless the presence of the α,β-unsaturated double bond, compound 6 showed interesting activity like 3. Compound 6 differs from 1 to 3 with the α,β-unsaturated double bond and its high lipophilicity turning this latter along with 3 as two pharmacophores to be explored for antimicrobial chemotherapy. Nevertheless, the high hydrophilicity of compound 18 reduced drastically its antimicrobial potency (Fig. 2). Concerning the activity of isoflavonoid, it also appeared that neobavaisoflavone (8) was another pharmacophoric moiety (Fig. 3). Any modification of the structure of compound 8 such as cyclisation or absence of prenyl group resulted in the reduction of antibacterial activity as it can be seen with compounds 7, 12 and 13.
Fig. 2

Pharmacophores (3 and 6) detected in flavonoids

Fig. 3

Representation of pharmacophoric scaffold detected in isoflavonoids

Discussion

Bacterial multidrug resistance represents a major hurdle in the treatment of infectious diseases. In the present study, we tested a panel of bacterial strains including both reference ATCC strains and MDR phenotypes expressing active efflux pumps (Kuete et al. 2010, 2011a; Fankam et al. 2011). In fact, tripartite drug efflux pumps, mainly those clinically reported as AcrAB–TolC in Enterobacteriaceae or as MexAB–OprM in Pseudomonas aeruginosa tested in the present study, play a key role in multidrug resistance of pathogenic Gram-negative bacteria (Nikaido 2009; Davin-Regli et al. 2008). Interestingly, a MIC value of 64 µg/mL was recorded with the best compounds (namely flavonoid 3 and isoflavonoid 8) against the problematic MDR strain P. aeruginosa PA124. This value was identical to that of the reference compound chloramphenicol (Table 1). The antimicrobial activity of a phytochemical has been defined as significant when MIC is below 10 µg/mL, moderate when 10 µg/mL < MIC < 100 µg/mL or low when MIC > 100 µg/mL (Kuete 2010; Kuete and Efferth 2010). In the present study, MIC values below 10 µg/mL were noted with compounds 3, 6 and 8 against several bacterial strains, highlighting their possible use in the control of bacterial infections. The activity of flavonoid 3 was better or equal to that of chloramphenicol in the majority of the bacteria including all tested K. pneumoniae, P. stuartii, E. aerogenes, E. cloacae and P. aeruginosa strains (Table 1). This was also the case with compounds 6 and 8 towards the majority of the tested bacterial strains and mostly the MDR phenotypes. Regarding the involvement of MDR bacteria in treatment failures and the re-emergence of infectious diseases (Blot et al. 2007; Falagas and Bliziotis 2007; Nicolle 2001), the activity of flavonoids 3, 6 and isoflavonoid 8 could be considered very promising. Pseudomonas aeruginosa is an important nosocomial pathogen highly resistant to clinically used antibiotics, causing a wide spectrum of infections and leading to substantial morbidity and mortality (Cardoso et al. 2007) and was found sensitive to the three compounds (3, 6 and 8). MDR Enterobacteriaceae, including K. pneumoniae, E. aerogenes, P. stuartii and E. coli, have also been classified as antimicrobial-resistant organisms of concern in healthcare facilities (Nicolle 2001; Tran et al. 2010). The analysis of data of Table 1 shows that MBC/MIC ratios below 4 were recorded with the three best compounds (3, 6 and 8) in many cases, suggesting that bacterial effects of these phytochemicals could be expected (Mims et al. 1993; Mbaveng et al. 2011, 2012). The data reported herein highlight once more the good pharmacological potential of flavonoids 3, 6 and isoflavonoid 8 and their ability to combat infections involving these bacterial species. Furthermore, the pharmacophoric moiety (8) suggests that hemi-synthesis reaction with neobavaisoflavone could be explored in more details for antibacterial drug development. To the best of our knowledge, the antibacterial activity of the best compounds (3, 6 and 8) against MDR bacteria is being reported for the first time. However, several flavonoids and isoflavonoids are known to possess antibacterial activities against both drug-sensitive and MDR Gram-negative phenotypes (Kuete et al. 2010, 2011a; Ndhlala et al. 2013; Ngameni et al. 2013).

Methods

General procedure

Column chromatography (CC) and thin layer chromatography (TLC) were performed over silica gel 60H (particle size 90 % <45 mm), 200–300 mesh silica gel silica gel GF254, respectively. 1D- and 2D-NMR spectra were carried out with a Bruker DRX-400 MHz. Melting points were measured by an Electro thermal IA 9000 digital melting point apparatus and are uncorrected.

Plant material

Plant species were collected in Yaoundé (Centre Region, Cameroon) and in Dschang (West Region, Cameroon) and identified by the specialist of the national herbarium in Yaoundé, Cameroon where their voucher are kept under the registration codes: Teclea afzelii Engl. (Rutaceae) (10674/SRF/Cam), Erythrina excelsa Baker (Fabaceae) (61487/HNC), Erythrina senegalensis A. Rich. (Fabaceae) (59409/HNC), Echinops giganteus A. Rich. (Asteraceae) (23647/SRF-Cam), Pachystela msolo Engl. (Sapotaceae) (3849/SRFK), Garcinia ovalifolia Oliv. (Guttiferae) (55523/HNC) and Alchornea laxiflora (Benth) Pax and Hoff (Euphorbiaceae) (45363HNC).

Ethics statement

For the collection of plants, no specific permits were required for the described field studies. For any location/activity, no specific permissions were required. All locations where the plants were collected were not privately-owned or protected in any way and the field studies did not involved endangered or protected species.

Extraction and isolation

Compounds tested in the present work were either previously isolated in our research team (1–10, 14) or newly isolated (12, 13, 15–19). Compounds 13 were obtained from the roots of Milicia excelsa whilst 4 was identified from the leaves as previously reported (Ouete et al. 2013, 2014). Compounds 5 and 6 were isolated from Echinops giganteus (Asteraceae) (Kuete et al. 2013), while 7 and 8 were obtained from Erythrina sigmoidea (Fabaceae) (Kuete et al. 2014). Compounds 9 and 10 were isolated from Zanthoxylum buesgenii (Rutaceae) (Sandjo et al. 2014). Compound 14 was isolated from Dorstenia elliptica (Moraceae) (Abegaz et al. 2004).

Compound 11 in addition to 9 and 10 were isolated from the roots of Teclea afzelii (Rutaceae); Hence, air-dried roots (7 kg) were macerated in MeOH/DCM (1:1, v/v) for 48 h and the organic (286 g) solid obtained after evaporation of the solvents in vacuo was further extracted with hexane (hex, 41 g), ethyl acetate (EA, 44 g) and MeOH (201 g). The EA fraction was purified by column chromatography on silica gel in gradient conditions of hex/EA. Three compounds were isolated as follows: 9 (6 mg), 10 (5 mg) and 11 (10 mg).

Compound 12 was obtained from the roots of Erythrina excelsa (2.2 kg) (Fabaceae); The crude extract obtained from the maceration of the air-dried roots was fractioned by silica gel flash chromatography using hex/EA in gradient conditions. The fraction issued from hex/EA (1:1) was chromatographed using the same condition as above from which 12 (45 mg) was isolated. Similarly, 13 (5 mg) was isolated from the roots of Erythrina senegalensis (Fabaceae) as described for 12. Compound 17 (5.0 mg) was isolated from the roots of Echinops giganteus; the powdered roots of E. giganteus (Asteraceae) was macerated successively in DCM/MeOH (1:1, v/v) and MeOH for 48 h and 24 h, respectively. The organic solutions were pooled together based on their TLC profile. Eighty-one grams of a red dark crude extract were obtained after evaporation in vacuo. Furthermore, the crude extract was poured onto water and extracted with Hex (A, 10 g), DCM (B, 25 g), EA (C, 30 g), n-butanol (D, 5 g). Fraction B was purified on silica gel CC using gradient conditions of Hex/EA and 17 was obtained from the Hex/EA (3:2, v/v). Similarly, bark powder (2.8 kg) of Pachystela msolo Engl. (Sapotaceae) was extracted with DCM/MeOH (1:1), yielding a dark crude extract (30 g). The purification of this later in gradient conditions of Hex/EA afforded 15 (5 mg). The stem bark (2.5 kg) of Garcinia ovalifolia (Guttiferaceae) was air-dried, ground and macerated in MeOH for 48 h. A brown residue (120 g) was obtained after concentrating the organic solution. Vacuum liquid chromatography was used for a first fractionation with gradient of hex/EA and EA/MeOH. Fractions obtained from Hex and Hex/EA (3:1, v/v) were pooled together (1.22 g) and purified by silica gel CC with gradients of the same mixture of solvents to afford 16 (12 mg). Fractions collected from EA/MeOH (9:1 and 4:1) were also pooled together and purified on silica gel CC with gradients of DCM/MeOH to yield compound 18 (90 mg). The stem bark (1.8 kg) of Alchornea Laxiflora (Euphorbiaceae) was macerated in MeOH. The concentrated methanol crude extract (30 g) was subjected to silica gel flash chromatography using Hex (A), EA (B) and MeOH (C). Fraction C (10 g) was purified by silica gel CC using the gradient of DCM/MeOH. Compound 19 (15 mg) was isolated from sub-fractions eluted with DCM/MeOH (95:5).

Antimicrobial assays

Chemicals for antimicrobial assay

Chloramphenicol ≥98 % (Sigma-Aldrich, St. Quentin Fallavier, France) was used as reference antibiotics (RA) against Gram-negative bacteria. p-Iodonitrotetrazolium chloride ≥97 % (INT, Sigma-Aldrich) was used as microbial growth indicator (Eloff 1998; Mativandlela et al. 2006).

Microbial strains and culture media

The studied microorganisms included sensitive and resistant strains of P. aeruginosa, K. pneumoniae, E. aerogenes, E. cloacae, E. coli, P. stuartii, obtained from the American Type Culture Collection. Their bacterial features were previously reported (Kuete et al. 2011a; Lacmata et al. 2012; Seukep et al. 2013; Touani et al. 2014). Nutrient agar were used for the activation of the tested Gram-negative bacteria (Kuete et al. 2011b).

INT colorimetric assay for MIC and MBC determinations

The minimal inhibitory concentration (MIC) determinations on the tested bacteria were conducted using rapid p-iodonitrotetrazolium chloride (INT) colorimetric assay according to described methods (Eloff 1998) with some modifications (Kuete et al. 2008b, 2009). The test samples and RA were first of all dissolved in DMSO/Mueller–Hinton Broth (MHB). The final concentration of DMSO was lower than 2.5 % and does not affect the microbial growth (Kuete et al. 2007, 2008a). The solution obtained was then added to Mueller–Hinton Broth, and serially diluted two fold (in a 96-wells microplate). One hundred microlitre (100 µL) of inoculum 1.5 × 106 CFU/mL prepared in appropriate broth was then added (Kuete et al. 2008b, 2009). The plates were covered with a sterile plate sealer, then agitated to mix the contents of the wells using a plate shaker and incubated at 37 °C for 18 h. The assay was repeated thrice. Wells containing adequate broth, 100 µL of inoculum and DMSO to a final concentration of 2.5 % served as negative control. The MIC of samples was detected after 18 h incubation at 37 °C, following addition (40 µL) of 0.2 mg/mL of INT and incubation at 37 °C for 30 min. Viable bacteria reduced the yellow dye to a pink. MIC was defined as the sample concentration that prevented the color change of the medium and exhibited complete inhibition of microbial growth (Eloff 1998). The minimal bactericidal concentration (MBC) was determined by adding 50 µL aliquots of the preparations, which did not show any growth after incubation during MIC assays, to 150 µL of adequate broth. These preparations were incubated at 37 °C for 48 h. The MBC was regarded as the lowest concentration of extract, which did not produce a color change after addition of INT as mentioned above (Kuete et al. 2008b, 2009).

Conclusion

Regarding the medical importance of the studied microorganisms, the results obtained and reported in this study interestingly showed how secondary metabolites are still a strong source of inspiration in drug discovery. Thus, the present data provided evidence that neocyclomorusin (3), candidone (6) and neobavaisoflavone (8) could be potential antimicrobial drugs to fight MDR bacterial infections and could also be used as motifs for developing related antibiotics with strong potency. To explore more the therapeutic values of the studied compounds, a combination with commonly used antibiotics will be further performed. Also, the study of the mechanism of action of the effective compounds will be carried out to better understand their inhibitory effects.

Declarations

Authors’ contributions

AMT, LPS, ST, and VK performed the study; AMT, LPS, ARN, PA, BTN and VK contributed to the isolation and/or identification of compounds. AMK, LPS and VK drafted the manuscript. VK designed the experiments; BTN and VK supervised the work; VK provided the facilities for the study. All authors read and approved the final manuscript.

Acknowledgements

Authors are thankful to the Cameroon National Herbarium (Yaounde) for the plant identification.

Authors are also thankful to UMR-MD1 (Mediterranean University, Marseille, France) for providing some clinical bacteria.

Competing interests

The authors declare that they have no competing interests.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Authors’ Affiliations

(1)
Department of Biochemistry, Faculty of Science, University of Dschang
(2)
Department of Pharmaceutical Sciences, CSS, Universitade Federal de Santa Catarina
(3)
Department of Organic Chemistry, Faculty of Science, University of Yaoundé I
(4)

References

  1. Abegaz BM, Ngadjui BT, Folefoc GN, Fotso S, Ambassa P, Bezabih M, Dongo E, Rise F, Petersen D (2004) Prenylated flavonoids, monoterpenoid furanocoumarins and other constituents from the twigs of Dorstenia elliptica (Moraceae). Phytochemistry 65(2):221–226View ArticleGoogle Scholar
  2. Ayafor J, Okogun J (1982) Isolation and identification of three new phenolic furoquinoline alkaloids from Teclea verdoorniana Exell and Mendonça (Rutaceae). J Chem Soc Perkin Trans 1:909–915View ArticleGoogle Scholar
  3. Basha G, Yadav S, Srinuvasarao R, Prasanthi S, Ramu T, Mangarao N, Siddaiah V (2013) A mild and efficient protocol to synthesize chromones, isoflavones, and homoisoflavones using the complex. Can J Chem 91:763–768View ArticleGoogle Scholar
  4. Bennett R, Hasegawa S (1981) Limonoids of calamondin seeds. Tetrahedron 37:17–24View ArticleGoogle Scholar
  5. Blot S, Depuydt P, Vandewoude K, De Bacquer D (2007) Measuring the impact of multidrug resistance in nosocomial infection. Curr Opin Infect Dis 20(4):391–396View ArticleGoogle Scholar
  6. Cardoso O, Alves AF, Leitao R (2007) Surveillance of antimicrobial susceptibility of Pseudomonas aeruginosa clinical isolates from a central hospital in Portugal. J Antimicrob Chemother 60(2):452–454View ArticleGoogle Scholar
  7. Cho JK, Ryu YB, Curtis-Long MJ, Kim JY, Kim D, Lee S, Lee WS, Park KH (2011) Inhibition and structural reliability of prenylated flavones from the stem bark of Morus lhou on beta-secretase (BACE-1). Bioorg Med Chem Lett 21(10):2945–2948View ArticleGoogle Scholar
  8. Davin-Regli A, Bolla JM, James CE, Lavigne JP, Chevalier J, Garnotel E, Molitor A, Pages JM (2008) Membrane permeability and regulation of drug “influx and efflux” in enterobacterial pathogens. Curr Drug Targets 9(9):750–759View ArticleGoogle Scholar
  9. Eloff JN (1998) A sensitive and quick microplate method to determine the minimal inhibitory concentration of plant extracts for bacteria. Planta Med 64(8):711–713View ArticleGoogle Scholar
  10. Falagas ME, Bliziotis IA (2007) Pandrug-resistant Gram-negative bacteria: the dawn of the post-antibiotic era? Int J Antimicrob Agents 29(6):630–636View ArticleGoogle Scholar
  11. Fankam AG, Kuete V, Voukeng IK, Kuiate JR, Pages JM (2011) Antibacterial activities of selected Cameroonian spices and their synergistic effects with antibiotics against multidrug-resistant phenotypes. BMC Complement Altern Med 11:104View ArticleGoogle Scholar
  12. Fischbach MA, Walsh CT (2009) Antibiotics for emerging pathogens. Science 325(5944):1089–1093View ArticleGoogle Scholar
  13. Gao X, Wu J, Zou W, Dai Y (2014) Two ellagic acids isolated from roots of Sanguisorba officinalis L. promote hematopoietic progenitor cell proliferation and megakaryocyte differentiation. Molecules 19:5448–5458View ArticleGoogle Scholar
  14. http://whqlibdoc.who.int/hq/2001/WHO_CDS_CSR_DRS_2001.7.pdf. Accessed October 2014
  15. Kuete V (2010) Potential of Cameroonian plants and derived products against microbial infections: a review. Planta Med 76(14):1479–1491View ArticleGoogle Scholar
  16. Kuete V, Efferth T (2010) Cameroonian medicinal plants: pharmacology and derived natural products. Front Pharmacol 1:123View ArticleGoogle Scholar
  17. Kuete V, Wabo GF, Ngameni B, Mbaveng AT, Metuno R, Etoa FX, Ngadjui BT, Beng VP, Meyer JJ, Lall N (2007) Antimicrobial activity of the methanolic extract, fractions and compounds from the stem bark of Irvingia gabonensis (Ixonanthaceae). J Ethnopharmacol 114(1):54–60View ArticleGoogle Scholar
  18. Kuete V, Ngameni B, Simo CC, Tankeu RK, Ngadjui BT, Meyer JJ, Lall N, Kuiate JR (2008a) Antimicrobial activity of the crude extracts and compounds from Ficus chlamydocarpa and Ficus cordata (Moraceae). J Ethnopharmacol 120(1):17–24View ArticleGoogle Scholar
  19. Kuete V, Wansi JD, Mbaveng AT, Kana Sop MM, Tadjong AT, Beng VP, Etoa FX, Wandji J, Meyer JJM, Lall N (2008b) Antimicrobial activity of the methanolic extract and compounds from Teclea afzelii (Rutaceae). S Afr J Bot 74(4):572–576View ArticleGoogle Scholar
  20. Kuete V, Nana F, Ngameni B, Mbaveng AT, Keumedjio F, Ngadjui BT (2009) Antimicrobial activity of the crude extract, fractions and compounds from stem bark of Ficus ovata (Moraceae). J Ethnopharmacol 124(3):556–561View ArticleGoogle Scholar
  21. Kuete V, Ngameni B, Tangmouo JG, Bolla JM, Alibert-Franco S, Ngadjui BT, Pages JM (2010) Efflux pumps are involved in the defense of Gram-negative bacteria against the natural products isobavachalcone and diospyrone. Antimicrob Agents Chemother 54(5):1749–1752View ArticleGoogle Scholar
  22. Kuete V, Alibert-Franco S, Eyong KO, Ngameni B, Folefoc GN, Nguemeving JR, Tangmouo JG, Fotso GW, Komguem J, Ouahouo BM, Bolla JM, Chevalier J, Ngadjui BT, Nkengfack AE, Pages JM (2011a) Antibacterial activity of some natural products against bacteria expressing a multidrug-resistant phenotype. Int J Antimicrob Agents 37(2):156–161View ArticleGoogle Scholar
  23. Kuete V, Kamga J, Sandjo LP, Ngameni B, Poumale HM, Ambassa P, Ngadjui BT (2011b) Antimicrobial activities of the methanol extract, fractions and compounds from Ficus polita Vahl. (Moraceae). BMC Complement Altern Med 11:6View ArticleGoogle Scholar
  24. Kuete V, Sandjo L, Wiench B, Efferth T (2013) Cytotoxicity and modes of action of four Cameroonian dietary spices ethno-medically used to treat Cancers: Echinops giganteus, Xylopia aethiopica, Imperata cylindrica and Piper capense. J Ethnopharmacol 149(1):245–253View ArticleGoogle Scholar
  25. Kuete V, Sandjo LP, Djeussi DE, Zeino M, Kwamou GM, Ngadjui B, Efferth T (2014) Cytotoxic flavonoids and isoflavonoids from Erythrina sigmoidea towards multi-factorial drug resistant cancer cells. Invest New Drugs 32:1053–1062View ArticleGoogle Scholar
  26. Kuster R, Robson R, Bernardo R, Da Silva A, Parente J, Mors W (1994) Furocoumarins from the rhizomes of Dorstenia brasiliensis. Phytochemistry 36:221–223View ArticleGoogle Scholar
  27. Lacmata ST, Kuete V, Dzoyem JP, Tankeo SB, Teke GN, Kuiate JR, Pages JM (2012) Antibacterial activities of selected Cameroonian plants and their synergistic effects with antibiotics against bacteria expressing MDR phenotypes. Evid Based Complement Alternat Med 2012:623723View ArticleGoogle Scholar
  28. Marti G, Eparvier V, Litaudon M, Grellier P, Guéritte F (2010) A new xanthone from the bark extract of Rheedia acuminata and antiplasmodial activity of its major compounds. Molecules 15:7106–7114View ArticleGoogle Scholar
  29. Mativandlela SPN, Lall N, Meyer JJM (2006) Antibacterial, antifungal and antitubercular activity of (the roots of) Pelargonium reniforme (CURT) and Pelargonium sidoides (DC) (Geraniaceae) root extracts. S Afr J Bot 72(2):232–237View ArticleGoogle Scholar
  30. Mbaveng AT, Kuete V, Mapunya BM, Beng VP, Nkengfack AE, Meyer JJ, Lall N (2011) Evaluation of four Cameroonian medicinal plants for anticancer, antigonorrheal and antireverse transcriptase activities. Environ Toxicol Pharmacol 32(2):162–167Google Scholar
  31. Mbaveng AT, Kuete V, Ngameni B, Beng VP, Ngadjui BT, Meyer JJ, Lall N (2012) Antimicrobial activities of the methanol extract and compounds from the twigs of Dorstenia mannii (Moraceae). BMC Complement Altern Med 12:83View ArticleGoogle Scholar
  32. Mims C, Playfair J, Roitt I, Wakelin D, Williams R (1993) Antimicrobials and chemotherapy. In: Mims CA, et al (eds) Med Microbiol Rev, vol. 35, pp 1–34Google Scholar
  33. Ndhlala AR, Amoo SO, Ncube B, Moyo M, Nair JJ, Van Staden J (2013) 16—antibacterial, antifungal, and antiviral activities of African medicinal plants. In: Kuete V (ed) Medicinal plant research in Africa: Pharmacology and Chemistry. Elsevier, Oxford, pp 621–659View ArticleGoogle Scholar
  34. Ngameni B, Fotso GW, Kamga J, Ambassa P, Abdou T, Fankam AG, Voukeng IK, Ngadjui BT, Abegaz BM, Kuete V (2013) 9—Flavonoids and related compounds from the medicinal plants of Africa. In: Kuete V (ed) Medicinal Plant Research in Africa: Pharmacology and Chemistry. Elsevier, Oxford, pp 301–350View ArticleGoogle Scholar
  35. Nicolle L (2001) Infection control programmes to contain antimicrobial resistance. World Health Organization, Geneva (WHO/CDS/CSR/DRS/20017) Google Scholar
  36. Nikaido H (2009) Multidrug resistance in bacteria. Annu Rev Biochem 78:119–146View ArticleGoogle Scholar
  37. Nkengfack AE, Vouffo TW, Fomum ZT, Meyer M, Bergendorff O, Sterner O (1994) Prenylated isoflavanone from the roots of Erythrina sigmoidea. Phytochemistry 36(4):1047–1051View ArticleGoogle Scholar
  38. Nkengfack AE, Vardamides JC, Fomum ZT, Meyer M (1995) Prenylated isoflavanone from Erythrina eriotricha. Phytochemistry 40(6):1803–1808View ArticleGoogle Scholar
  39. Noguchi A, Yoshihara T, Ichihara A, Sugihara S, Koshino M, Kojima M, Masaoka Y (1994) Ferric phosphate-dissolving compound, alfafuran, from alfalfa (Medicago sativa L.) in response to iron-deficiency stress. Biosci Biotechnol Biochem 58:2312–2313View ArticleGoogle Scholar
  40. Nunes F, Barros-Filho B, de Oliveira M, Andrade-Neto M, de Mattos M, Mafezoli J, Pirani J (2005) 1H and 13C NMR spectra of 3,8-dimethoxyfuro[3,2-g] coumarin and maculine from Esenbeckia grandiflora Martius (Rutaceae). Magn Reson Chem 43:864–866View ArticleGoogle Scholar
  41. Ouete JL, Sandjo LP, Kapche DW, Liermann JC, Opatz T, Simo IK, Ngadjui BT (2013) A new flavone from the roots of Milicia excelsa (Moraceae). Z Naturforsch C 68(7–8):259–263View ArticleGoogle Scholar
  42. Ouete JL, Sandjo LP, Kapche DW, Yeboah SO, Mapitse R, Abegaz BM, Opatz T, Ngadjui BT (2014) Excelsoside: a new benzylic diglycoside from the leaves of Milicia excelsa. Z Naturforsch C 69(7–8):271–275Google Scholar
  43. Rawat P, Kumar M, Sharan K, Chattopadhyay N, Maurya R (2009) Ulmosides A and B: flavonoid 6-C-glycosides from Ulmus wallichiana, stimulating osteoblast differentiation assessed by alkaline phosphatase. Bioorg Med Chem Lett 19:4684–4687View ArticleGoogle Scholar
  44. Rice LB (2006) Unmet medical needs in antibacterial therapy. Biochem Pharmacol 71(7):991–995View ArticleGoogle Scholar
  45. Saleem M, Nazir M, Ali MS, Hussain H, Lee YS, Riaz N, Jabbar A (2010) Antimicrobial natural products: an update on future antibiotic drug candidates. Nat Prod Rep 27(2):238–254View ArticleGoogle Scholar
  46. Sandjo LP, Kuete V, Tchangna RS, Efferth T, Ngadjui BT (2014) Cytotoxic benzophenanthridine and furoquinoline alkaloids from Zanthoxylum buesgenii (Rutaceae). Chem Cent J 8(1):61View ArticleGoogle Scholar
  47. Seukep JA, Fankam AG, Djeussi DE, Voukeng IK, Tankeo SB, Noumdem JA, Kuete AH, Kuete V (2013) Antibacterial activities of the methanol extracts of seven Cameroonian dietary plants against bacteria expressing MDR phenotypes. Springerplus 2:363View ArticleGoogle Scholar
  48. Shi J, Zhang X, Jiang H (2010) 2-(penta-1,3-diynyl)-5-(3,4-dihydroxybut-1-ynyl)thiophene, a novel NQO1 inducing agent from Echinops grijsii Hance. Molecules 15:5273–5281View ArticleGoogle Scholar
  49. Touani FK, Seukep AJ, Djeussi DE, Fankam AG, Noumedem JA, Kuete V (2014) Antibiotic-potentiation activities of four Cameroonian dietary plants against multidrug-resistant Gram-negative bacteria expressing efflux pumps. BMC Complement Altern Med 14:258View ArticleGoogle Scholar
  50. Tran QT, Mahendran KR, Hajjar E, Ceccarelli M, Davin-Regli A, Winterhalter M, Weingart H, Pages JM (2010) Implication of porins in beta-lactam resistance of Providencia stuartii. J Biol Chem 285(42):32273–32281View ArticleGoogle Scholar
  51. Wang D, Li F, Jiang Z (2001) Osteoblastic proliferation stimulating activity of Psoralea corylifolia extracts and two of its flavonoids. Planta Med 67:748–749View ArticleGoogle Scholar
  52. Wiedemann B, Lerche H, Lotter H, Neszmelyi A, Wagner H, Müller A (1999) Two novel triterpenoids from the stemwood of Herrania cuatrecasana. Phytochemistry 52:333–337View ArticleGoogle Scholar

Copyright

© Mbaveng et al. 2015